首页 > 市场调查报告书 > 医疗设备

伤口护理

市场调查报告书

商品编码

1439674

糖尿病伤口 - 全球市场回顾、竞争格局、市场预测 (2030)

Diabetic Wounds - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

全球糖尿病伤口市场规模将于2023年达到22.2亿美元，到2030年将达到34.4亿美元，预计2024-2030年期间复合年增长率为7.48%。由于糖尿病盛行率上升、人群中糖尿病足溃疡发病率增加、新的活性疗法的推出以及因糖尿病足溃疡而截肢的人数迅速增加等因素推动了市场的发展，该市场呈现正增长预测期内的增长。

糖尿病伤口市场动态

随着世界各地糖尿病盛行率的不断上升，对糖尿病伤口护理和相关设备的需求可能会增加。这是因为不受控制的糖尿病会导致糖尿病伤口的发展，尤其是糖尿病足溃疡。

例如，根据国际糖尿病联盟 2019 年报告，2019 年约有 4.63 亿成年人患有糖尿病，预计到 2045 年这一数字将增至 7 亿。因此，越来越多的糖尿病患者可能会带来发生糖尿病伤口的潜在风险，从而增加对治疗设备的需求。

此外，低收入和中等收入国家糖尿病盛行率的不断上升也可能是导致这些地区患者出现糖尿病伤口的一个因素，从而导致市场成长。

55 个低收入和中等收入国家的糖尿病治疗覆盖率状况：Flood D. 等人对 680 102 个国家具有代表性的个人数据进行的横断面研究，发表于 LANCET (2022)全球4.63 亿成人糖尿病患者中，约80% 生活在低收入和中等收入国家。

其他可能导致糖尿病的潜在危险因素，例如人口老化加剧、久坐的生活方式和肥胖日益增加，也可能增加糖尿病伤口等糖尿病相关疾病的风险。

因此，上述因素预计将有助于预测期内糖尿病伤口治疗市场的成长。

然而，溃疡管理的高成本和治疗设备的严格规定可能会对糖尿病伤口市场的成长产生一定的限制。

持续的 COVID-19 大流行影响了糖尿病伤口市场。这是因为世界各地的医疗保健系统在向患者提供糖尿病足病理服务方面面临严峻的挑战。此外，关于社交距离和屏蔽的公共卫生指南也影响糖尿病足病变治疗服务的提供。

糖尿病伤口细分市场分析

在糖尿病伤口市场的产品类型领域，泡棉敷料预计在预测期（2024-2030年）将占较高占有率。各种泡棉敷料的出现，例如黏合边框、硅胶边框和可变孔径（小、中、大），可能会在未来几年推动泡棉敷料市场的发展。

此外，对泡棉敷料的持续研究和研究及其结果预计将有助于泡棉敷料市场的成长。

例如，2022 年3 月，Smith + Nephew 在西班牙进行的一项实地研究中发现，改用ALLEVYN LIFE 泡棉敷料提高了社区环境中的临床医生和患者护理满意度，同时提高了我们发表的正面结果，有助于显着减少变化频率和每週穿衣费用。

此外，近年来该产品线的产品核准也是导致泡棉敷料市场成长的因素。

本报告研究和分析了全球糖尿病伤口市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

推动糖尿病伤口市场的因素
- 糖尿病盛行率不断上升
- 人们罹患糖尿病足溃疡的人数增加
- 推出新的活性疗法
- 因糖尿病足溃疡导致截肢的人数激增
糖尿病伤口市场的限制与挑战
- 溃疡管理成本高昂
- 对治疗设备的严格规定
糖尿病伤口市场机遇
- 有机会采用皮肤替代品等新疗法
- 低收入和中等收入国家的成长机会

第5章糖尿病伤口市场波特五力分析

第6章COVID-19对糖尿病伤口市场的影响分析

第7章糖尿病伤口市场布局

依产品类型
- 伤口护理敷料
- 伤口护理设备
- 植皮、皮肤替代品
- 生长因子
- 其他
按伤口类型
- 神经性溃疡伤口
- 缺血性溃疡伤口
- 神经缺血性溃疡伤口
按最终用户
- 医院
- 专科诊所
按地区
- 北美
- 欧洲
- 亚太地区
- 其他领域

第 8 章糖尿病伤口市场：全球公司占有率分析 - 3 至 5 家主要公司

第 9 章糖尿病伤口市场公司与产品简介

B Braun Meslungen AG
MEDCu
3M
Integra LifeSciences
Organogenesis Inc
Bharat Biotech
RLS Global
Coloplast Corp
ConvaTec Inc.
Cardinal Health
BSN medical Inc
HARTMANN USA, Inc
Mil Laboratories
Hollister Incorporated
DermaRite Industries, LLC
Molnlycke Health Care AB
Osiris (Smith&Nephew)
Lohmann & Rauscher
Medela AG
DeRoyal

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

简介目录图表

Product Code: DIMDCL0514

Diabetic Wounds Market By Product Type (Wound Care Dressings [Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Silver Dressings, Hydrocolloid Dressings, Hydro Fiber Dressings, Others], Wound Care Devices [Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others], Skin Grafts & Substitutes, Growth Factors, Others), By Wound Type (Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds), By End-User (Hospitals, Specialty Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population

Global Diabetic Wounds Market was valued at USD 2.22 Billion in 2023, growing at a CAGR of 7.48% during the forecast period from 2024 to 2030 to reach USD 3.44 Billion by 2030. The Diabetic Wounds market is witnessing positive growth owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population, launch of novel active therapies, a surge in the number of amputations due to diabetic foot ulcers, thereby contributing to the growth of the Diabetic Wounds market during the forecast period from 2024-2030.

Diabetic Wounds Market Dynamics:

The rising Prevalence of Diabetes among the population across the globe is likely to increase the demand for diabetic wound treatment therapies and associated devices. This is because uncontrolled diabetes mellitus can lead to the development of diabetic wounds especially diabetic foot ulcers among the population.

For instance, according to the International Diabetes Federation 2019 report, approximately 463 million adults were suffering from diabetes in the year 2019 and it was estimated to rise to 700 million by the year 2045. Thus, rising diabetes cases could be a potential risk for developing diabetic wounds thereby increasing the need for treatment devices.

Moreover, rising diabetes cases in the low and middle-income countries could also be a factor that could lead to diabetic wounds in the patient in these regions ultimately leading to market growth.

According to the study: The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults by Flood D. et al. published in the LANCET 2022, approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries.

Rising old age population, sedentary lifestyle, increase in obesity, and other factors that are potential risk factors for diabetes could also increase the risk for diabetic associated disorders such as diabetic wounds.

Therefore the above-mentioned factors will contribute to the market growth for diabetic wounds treatment therapy during the forecasted period.

However, the high cost of ulcer management and stringent regulations of the treatment devices may be certain limiting factors of the Diabetic Wounds market growth.

The ongoing COVID-19 pandemic has impacted the market for Diabetic Wound. This is because healthcare systems across the globe are facing tough challenges in delivering diabetic foot services to patients. Moreover, social distancing and shielding public health guidelines have also impacted diabetic foot treatment services delivery.

Diabetic Wounds Market Segment Analysis:

Diabetic Wounds Market By Product Type (Wound Care Dressings [Foam Dressings, Antimicrobial Dressings, Hydrogel Dressings, Alginate Dressings, Silver Dressings, Hydrocolloid Dressings, Hydro fiber Dressings, Others], Wound Care Devices [Negative Pressure Wound Therapy Devices, Hyperbaric & Oxygen Therapy Devices, Debridement Devices, Others], Skin Grafts & Substitutes, Growth factors, Others), By Wound Type (Neuropathic Ulcer Wounds, Ischemic Ulcer Wounds, Neuro-Ischemic Ulcer Wounds), By End-User (Hospitals, Specialty Clinics, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Diabetic Wounds market, Foam Dressings are estimated to hold a higher share in the Diabetic Wounds market during the forecast period (2024-2030). Availability of a variety of foam dressings such as adhesive borders, silicone borders, with variable pore sizes from (small, medium, and large) is likely to boost the market for foam dressing during the forthcoming years.

Moreover, ongoing research studies on foam dressings and positive results out of those studies will also contribute to the market growth of the foam dressings.

For instance, in March 2022, Smith+Nephew announced positive results from a real-world study from Spain that showed how a switch to ALLEVYN LIFE Foam Dressings helped to significantly reduce dressing change frequency and weekly dressing costs while improving treatment satisfaction for clinicians and patients in a community setting.

Furthermore, recent product approval in the product line is also a factor that could lead to the market growth of foam dressings.

For instance, on May 14, 2020, Winner Medical Co., Ltd., a medical and health company based in China received FDA approval for PHMB Foam Dressing Non-Adhesive, PHMB Foam Dressing Adhesive, Silicone PHMB Foam Dressing, and Silicone PHMB Foam Dressing with Border indicated for use in the management of post-surgical incisions, pressure sores, venous stasis ulcers, diabetic ulcers, among other chronic and acute wounds.

Hence all the factors will augment the market for foam dressings during the forthcoming period.

North America is expected to dominate the overall Diabetic Wounds Market:

Among all the regions, North America is expected to account for the largest share in the Global Diabetic Wounds market. The rise in the prevalence of diabetic foot ulcers in the North America region is likely to bolster the market for diabetic wound treatment in the region.

According to an article, Epidemiology and Burden of Diabetic Foot Ulcer and Peripheral Arterial Disease in Korea by Chun D.I. et al., published in the NCBI 2019, the prevalence of DFU (diabetic foot ulcer) in North America was approximately 13% of the overall global DFU prevalence.

Also, the rising burden of diabetes could be a potential risk factor for DFU in the region. As per the National Statistics Diabetes 2020 report, approximately 34.2 million Americans are suffering from diabetes.

In addition, the presence of key players such as 3M company, Coloplast, Cardinal Health, among others in the region is anticipated to boost the market for the Diabetic wound in the region.

Furthermore, the launch of programs by leading wound care expert companies will also contribute to the diabetic wound market growth in the region.

For instance, in January 2022, Healogics® launched a program to make 2022 the Year of Healing for the patients and for people struggling with a wound that will not heal. The program is dedicated to empowering both patients and healthcare providers with resources to help improve health, heal wounds and prevent unnecessary amputations.

Thus, all the aforementioned factors are going to fuel the market for diabetic wounds in the region.

Diabetic Wounds Market Key Players:

Some of the key market players operating in the Diabetic Wounds market include B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, Coloplast Corp, ConvaTec Inc., Cardinal Health, BSN medical Inc, HARTMANN USA, Inc, Mil Laboratories, Hollister Incorporated, DermaRite Industries, LLC, Molnlycke Health Care AB, Osiris (Smith&Nephew), Lohmann & Rauscher, Medela AG, DeRoyal and others.

Recent Developmental Activities in the Diabetic Wounds Market:

In April 2022, Joerns Healthcare and Medela announced a nationwide partnership to develop access to innovative negative pressure wound therapy systems. Through this agreement, Joerns will expand its wound care portfolio to include the full Medela line of negative pressure wound therapy products, including the Invia Liberty and Invia Motion 60 NPWT Systems.

In June 2019, 3M acquired Acelity L.P. Inc. for $6.7 billion to enhance its strategy for advanced wound care solutions and accelerate the penetration of NPWT products internationally.

Key Takeaways from the Diabetic Wounds Market Report Study

Market size analysis for current Diabetic Wounds market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Diabetic Wounds market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the global Diabetic Wounds market.
Various opportunities available for the other competitor in the Diabetic Wounds market space.
What are the top performing segments in 2023? How these segments will perform in 2026.
Which is the top-performing regions and countries in the current Diabetic Wounds market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Diabetic Wounds market growth in the coming future?

Target Audience who can be benefited from this Diabetic Wounds Market Report Study

Diabetic Wounds products providers
Research organizations and consulting companies
Diabetic Wounds-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Diabetic Wounds
Various End-users who want to know more about the Diabetic Wounds market and latest technological developments in the Diabetic Wounds market.

Frequently Asked Questions for the Diabetic Wounds Market:

1. What are Diabetic Wounds?

Wounds can develop anywhere on the body, but diabetics are most vulnerable to cuts, scrapes, and sores on their lower extremities. When a person has diabetes, wounds can take longer to heal, which can increase the risk of infections and other complications developing.

2. What is the market for Global Diabetic Wounds?

Global Diabetic Wounds Market was valued at USD 2.22 Billion in 2023, growing at a CAGR of 7.48% during the forecast period from 2024 to 2030 to reach USD 3.44 Billion by 2030.

3. What are the drivers for the Global Diabetic Wounds Market?

The Diabetic Wounds market is witnessing a positive market growth owing to the rising prevalence of diabetes, increase in diabetic foot ulcers among the population, the launch of novel active therapies, a surge in the number of amputations due to diabetic foot ulcers, thereby contributing to the growth of the Diabetic Wounds market during the forecast period from 2024-2030

4. Who are the key players operating in the Global Diabetic Wounds Market?

5. Which region has the highest share in the Diabetic Wounds Market?

North America is expected to hold the highest share in the revenue in the Diabetic Wounds market during the forecast period. The rise in the prevalence of diabetic foot ulcers in the North America region is likely to bolster the market for diabetic wound treatment in the region.

1.Diabetic Wounds Market Report Introduction

2.Diabetic Wounds Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Diabetic Wounds Market Key Factors Analysis

4.1. Diabetic Wounds Market Drivers
- 4.1.1. Rising Prevalence of Diabetes
- 4.1.2. Increase in Diabetic Foot Ulcer among the population
- 4.1.3. Launch of novel active therapies
- 4.1.4. A surge in the Number of Amputations Due to Diabetic Foot Ulcers
4.2. Diabetic Wounds Market Restraints and Challenges
- 4.2.1. High cost of ulcer management
- 4.2.2. Stringent Regulatory of the treatment devices
4.3. Diabetic Wounds Market Opportunities
- 4.3.1. Opportunities with the incorporation of new treatment therapies such as skin substitutes
- 4.3.2. Growth opportunities in Low and Middle-income nations

5. Diabetic Wounds Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Diabetic Wounds Market

7. Diabetic Wounds Market Layout

7.1. By Product Type
- 7.1.1. Wound Care Dressings
  - 7.1.1.1. Foam Dressings
  - 7.1.1.2. Antimicrobial Dressings
  - 7.1.1.3. Hydrogel Dressings
  - 7.1.1.4. Alginate Dressings
  - 7.1.1.5. Silver Dressings
  - 7.1.1.6. Hydrocolloid Dressings
  - 7.1.1.7. Hydro fiber Dressings
  - 7.1.1.8. Others
- 7.1.2. Wound Care Devices
  - 7.1.2.1. Negative Pressure Wound Therapy Devices
  - 7.1.2.2. Hyperbaric & Oxygen Therapy Devices
  - 7.1.2.3. Debridement Devices
  - 7.1.2.4. Others
- 7.1.3. Skin Grafts & Substitutes
- 7.1.4. Growth factors
- 7.1.5. Others
7.2. By Wound Type
- 7.2.1. Neuropathic Ulcer Wounds
- 7.2.2. Ischemic Ulcer Wounds
- 7.2.3. Neuro-Ischemic Ulcer Wounds
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. North America Diabetic Wounds Market, by Country
  - 7.4.1.1.1. United States
  - 7.4.1.1.2. Canada
  - 7.4.1.1.3. Mexico
- 7.4.2. Europe
  - 7.4.2.1. Europe Diabetic Wounds Market, by Country
  - 7.4.2.1.1. France
  - 7.4.2.1.2. Germany
  - 7.4.2.1.3. United Kingdom
  - 7.4.2.1.4. Italy
  - 7.4.2.1.5. Spain
  - 7.4.2.1.6. Russia
  - 7.4.2.1.7. Rest of Europe
- 7.4.3. Asia-Pacific
  - 7.4.3.1. Asia-Pacific Diabetic Wounds Market, by Country
  - 7.4.3.1.1. China
  - 7.4.3.1.2. Japan
  - 7.4.3.1.3. India
  - 7.4.3.1.4. Australia
  - 7.4.3.1.5. South Korea
  - 7.4.3.1.6. Rest of Asia Pacific
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. RoW Diabetic Wounds Market, by Country
  - 7.4.4.1.1. Middle East
  - 7.4.4.1.2. Africa
  - 7.4.4.1.3. South America

8. Diabetic Wounds Market Global Company Share Analysis - Key 3-5 Companies

9. Diabetic Wounds Market Company and Product Profiles

9.1. B Braun Meslungen AG
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4. Product Listing
- 9.1.5. Entropy
9.2. MEDCu
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4. Product Listing
- 9.2.5. Entropy
9.3. 3M
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4. Product Listing
- 9.3.5. Entropy
9.4. Integra LifeSciences
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5. Organogenesis Inc
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4. Product Listing
- 9.5.5. Entropy
9.6. Bharat Biotech
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4. Product Listing
- 9.6.5. Entropy
9.7. RLS Global
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4. Product Listing
- 9.7.5. Entropy
9.8. Coloplast Corp
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4. Product Listing
- 9.8.5. Entropy
9.9. ConvaTec Inc.
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4. Product Listing
- 9.9.5. Entropy
9.10. Cardinal Health
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4. Product Listing
- 9.10.5. Entropy
9.11. BSN medical Inc
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4. Product Listing
- 9.11.5. Entropy
9.12. HARTMANN USA, Inc
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4. Product Listing
- 9.12.5. Entropy
9.13. Mil Laboratories
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4. Product Listing
- 9.13.5. Entropy
9.14. Hollister Incorporated
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4. Product Listing
- 9.14.5. Entropy
9.15. DermaRite Industries, LLC
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4. Product Listing
- 9.15.5. Entropy
9.16. Molnlycke Health Care AB
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4. Product Listing
- 9.16.5. Entropy
9.17. Osiris (Smith&Nephew)
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4. Product Listing
- 9.17.5. Entropy
9.18. Lohmann & Rauscher
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4. Product Listing
- 9.18.5. Entropy
9.19. Medela AG
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4. Product Listing
- 9.19.5. Entropy
9.20. DeRoyal
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4. Product Listing
- 9.20.5. Entropy